Lannett Co., Inc.

( )
LCI PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. -5.12%51.490.9%$2175.18m
JNJJohnson & Johnson 2.22%162.920.7%$1364.82m
MRKMerck & Co., Inc. 0.12%73.430.7%$1062.62m
BMYBristol-Myers Squibb Co. 0.92%56.841.0%$817.37m
LLYEli Lilly & Co. 0.30%246.311.1%$708.15m
ABBVAbbVie, Inc. 2.10%121.341.9%$636.90m
AZNAstraZeneca Plc 2.18%55.411.0%$312.60m
NVSNovartis AG 0.66%80.530.2%$173.30m
GSKGlaxoSmithKline Plc 1.21%41.750.2%$159.14m
DRNADicerna Pharmaceuticals, Inc. -0.18%38.180.3%$155.33m
VTRSViatris, Inc. 1.97%12.440.0%$148.48m
RPRXRoyalty Pharma Plc 0.64%37.890.1%$117.35m
BFRIBiofrontera, Inc. -0.47%4.250.0%$113.12m
RGENRepligen Corp. -5.82%247.596.7%$93.01m
NVONovo Nordisk A/S 0.63%107.750.1%$82.81m

Company Profile

Lannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. It offers products in different forms including capsules, tablets, liquids, powders, and sprays. The company was founded in 1942 and is headquartered in Trevose, PA.